• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EMD 3.23% 3.0¢

EMYRIA LIMITED

Emyria Limited is an Australia-based clinical services and drug development company. The... Emyria Limited is an Australia-based clinical services and drug development company. The Company is focused on developing patient outcomes in neuroscience and mental health through its clinical service delivery, proprietary real-world data (RWD), and drug discovery & development. It delivers evidence-based and emerging therapies for mental health and other unmet needs through its Emerald Clinics and the Pax Centre. Emerald Clinics specializes in providing treatments for patients with complex and chronic conditions. The Pax Centre specializes in treating individuals grappling with the psychological impacts of traumatic experiences. Through its advanced data platform operated by Palantir, the Company collects robust and ethically sourced real-world data to improve its care models and support its distinct therapy and drug development initiatives. The Company is also developing several proprietary ultra-pure cannabinoid dose forms and advancing them towards registration, such as EMD-RX5.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EMD
FDA
28/08/24 31 7.7K
28/08/24 Last post  yihao Comments Created with Sketch.  31  Views Created with Sketch.  7.7K 
EMD 21/08/24 1 568
21/08/24 Last post  rasberry Comments Created with Sketch.  1  Views Created with Sketch.  568 
EMD 08/08/24 8 2.4K
08/08/24 Last post  rasberry Comments Created with Sketch.  8  Views Created with Sketch.  2.4K 
EMD 19/07/24 0 361
19/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  361 
EMD 19/07/24 0 185
19/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  185 
EMD
general talk
4 5 6
19/07/24 350 127K
19/07/24 Last post  Alaska1 Comments Created with Sketch.  350  Views Created with Sketch.  127K 
EMD 15/07/24 0 374
15/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  374 
EMD 15/07/24 0 305
15/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  305 

See All Discussions arrow Created with Sketch.

Timeline

Results of Meeting
21 Aug 16:43
 
June 2024 Quarterly Activities Report and Appendix 4C
30 Jul 09:06
 
Letter to Shareholders - Notice of General Meeting
19 Jul 11:08
 
Notice of General Meeting/Proxy Form
19 Jul 11:08
 
Becoming a substantial holder
15 Jul 19:14
 
Ceasing to be a substantial holder
15 Jul 19:12
 
View More arrow Created with Sketch.
(20min delay)
Last
3.0¢
Change
-0.001(3.23%)
Mkt cap ! $12.67M
Open High Low Value Volume
3.0¢ 3.0¢ 3.0¢ $300 10.00K

Buyers (Bids)

No. Vol. Price($)
3 277844 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 97269 2
View Market Depth
Last trade - 10.02am 30/08/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.